Generic name Dosage form Drug class Indications Strengths Dose per injection semaglutide injection, solution GLP-1 Agonists weight loss 1 mg/1.5 ml0.68 mg/ml 0.25mg injection, solutionGLP-1 Agonistsweight loss2 mg/1.5 ml(1.34 mg/ml)0.5mg injection, solutionGLP-1 Agonistsweight loss4 mg/3 ml(1.34 mg/ml)1mg injection, solutionGLP-1 Agonistsweight loss6.8 mg/3 ml(2.27 mg/ml)1.7mg injection, solutionGLP-1 Agonistsweight loss9.6 mg/3 mL(3.2 mg/ml)2.4mg injection, solutionGLP-1 AgonistsType 2 DM2 mg/1.5 ml(1.34 mg/ml)0.25mg/0.5mg injection, solutionGLP-1 AgonistsType 2 DM4 mg/3 ml(1.34 mg/ml)0.5mg/1.0mg
28 people find this information helpful Disclaimer We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers
[52] TMAO is a metabolite produced by gut bacteria, and high levels have been linked to a variety of cardiovascular diseases
Patients should report any worsening of nausea, unusual diarrhea, or inability to tolerate either medication to their prescriber within 48 hours
Tirzepatide is intended to complement a reduced-calorie diet and regular physical activity rather than replace these habits